Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...
In this GEN webinar, our subject matter experts, Dr. Lee Fader, Dr. Jeremy Dupaul-Chicoine, and Dr. Maximilian Ebert, will provide an overview of current methodologies and technological innovations ...
A few companies are in clinicals with novel approaches to heal an initial brain injury or minimize secondary damage. Slow progress may be more related to investors’ misperceptions of the topic than ...
What especially shook investors was the prospect that China may have closed the tech gap with the United States in AI and especially DeepSeek’s claim that it developed R1 for just $5.6 million—a far ...